Oncology navigators’ perceptions of cancer-related financial burden and financial assistance resources
- 595 Downloads
As the cost of cancer treatment continues to rise, many patients are faced with significant emotional and financial burden. Oncology navigators guide patients through many aspects of care and therefore may be especially aware of patients’ financial distress. Our objective was to explore navigators’ perception of their patients’ financial burden and their role in addressing financial needs.
Materials and methods
We conducted a real-time online survey of attendees at an oncology navigators’ association conference. Participants included lay navigators, oncology nurse navigators, community health workers, and social workers. Questions assessed perceived burden in their patient population and their role in helping navigate patients through financial resources. Answers to open-ended questions are reported using identified themes.
Seventy-eight respondents participated in the survey, reporting that on average 75% of their patients experienced some degree of financial toxicity related to their cancer. Only 45% of navigators felt the majority of these patients were able to get some financial assistance, most often through assistance with medical costs (73%), subsidized insurance (36%), or non-medical expenses (31%). Commonly identified barriers for patients obtaining assistance included lack of resources (50%), lack of knowledge about resources (46%), and complex/duplicative paperwork (20%).
Oncology navigators reported a high burden of financial toxicity among their patients but insufficient knowledge or resources to address this need. This study underscores the importance of improved training and coordination for addressing financial burden, and the need to address community and system-level barriers.
KeywordsOncology navigator Financial assistance Financial toxicity
Funding for this project was provided through the National Comprehensive Cancer Network and Pfizer Independent Grants for Learning & Change (PI: Wheeler and Rosenstein). Ms. Sellers reports payment as a consultant with Pfizer which was unrelated to the submitted work.
Compliance with ethical standards
Conflict of interest
None of the above authors have any conflicts of interest to disclose, beyond receiving independent grant funding from Pfizer. Informed consent was obtained from all individual participants included in the study. Results of this study have not been published or presented previously.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
- 3.Yabroff KR, Dowling EC, Guy GP, Banegas MP, Davidoff A, Han X, Virgo KS, McNeel TS, Chawla N, Blanch-Hartigan D, Kent EE, Li C, Rodriguez JL, De Moor JS, Zheng Z, Jemal A, Ekwueme DU (2016) Financial hardship associated with cancer in the United States: findings from a population-based sample of adult cancer survivors. J Clin Oncol. https://doi.org/10.1200/JCO.2015.62.0468
- 4.de Souza JA, Wong Y-N (2013) Financial distress in cancer patients. J Med Person 11.2:73–77Google Scholar
- 5.Zafar SY et al (2014) Population-based assessment of cancer survivors' financial burden and quality of life: a prospective cohort study. J Oncol Pract 11.2:145–150Google Scholar
- 6.Ramsey S et al (2013) Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. Health Aff 32.6:1143–1152Google Scholar
- 7.Chongpison Y, Hornbrook MC, Harris RB, Herrinton LJ, Gerald JK, Grant M, Bulkley JE, Wendel CS, Krouse RS (2016) Self-reported depression and perceived financial burden among long-term rectal cancer survivors. Psychooncology. https://doi.org/10.1002/pon.3957
- 8.Kale HP, Carroll NV (2016) Self-reported financial burden of cancer care and its effect on physical and mental health-related quality of life among US cancer survivors. Cancer. https://doi.org/10.1002/cncr.29808
- 10.Ramsey SD, Bansal A, Fedorenko CR, Blough DK, Overstreet KA, Shankaran V, Newcomb P (2016) Financial insolvency as a risk factor for early mortality among patients with cancer. J Clin Oncol. https://doi.org/10.1200/JCO.2015.64.6620
- 11.Jagsi R, Pottow JAE, Griffith KA, Bradley C, Hamilton AS, Graff J, Katz SJ, Hawley ST (2014) Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries. J Clin Oncol. https://doi.org/10.1200/JCO.2013.53.0956
- 12.Smith SK, Nicolla J, Zafar SY (2014) Bridging the gap between financial distress and available resources for patients with cancer: A qualitative study. J Oncol Pract 10.5:e368–e372Google Scholar
- 16.Rocque GB, Pisu M, Jackson BE, Kvale EA, Demark-Wahnefried W, Martin MY, Meneses K, Li Y, Taylor RA, Acemgil A, Williams CP, Lisovicz N, Fouad M, Kenzik KM, Partridge EE (2017) Resource use and Medicare costs during lay navigation for geriatric patients with cancer. JAMA Oncol. https://doi.org/10.1001/jamaoncol.2016.6307
- 17.Rodday AM et al (2015) Impact of patient navigation in eliminating economic disparities in cancer care. Cancer 121.22:4025–4034Google Scholar
- 18.Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, Cannady RS, Pratt-Chapman ML, Edge SB, Jacobs LA, Hurria A, Marks LB, LaMonte SJ, Warner E, Lyman GH, Ganz PA (2016) American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. J Clin Oncol 34:611–635. https://doi.org/10.1200/JCO.2015.64.3809 CrossRefPubMedGoogle Scholar
- 19.Page AEK, Adler NE eds. (2008) Cancer care for the whole patient: Meeting psychosocial health needs. National Academies PressGoogle Scholar
- 21.Zafar SY et al (2013) The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. The oncologist 18.4:381–390Google Scholar
- 23.Zafar Y (2016) Financial toxicity of cancer care: It’s time to intervene. JNCI: J Natl Cancer Inst 108.5Google Scholar
- 24.Souza JA et al (2017) Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST). Cancer 123.3:476–484Google Scholar
- 25.O’Connor J, Kircher S, de Souza J (2016) Financial toxicity in cancer care. J Community Support Oncol 14:101–106. https://doi.org/10.12788/jcso.0239
- 26.Harris JK, Cyr J, Carothers BJ, Mueller NB, Anwuri VV, James AI (2011) Referrals among cancer services organizations serving underserved cancer patients in an urban area. Am J Public Health 101:1248–1252. https://doi.org/10.2105/AJPH.2010.300017
- 27.Choudhry NK, Lee JL, Agnew-Blais J, Corcoran C, Shrank WH (2009) Drug company-sponsored patient assistance programs: a viable safety net? Health Aff (Millwood) 28:827–834. https://doi.org/10.1377/hlthaff.28.3.827
- 29.Mathews M, Buehler S, West R (2009) Perceptions of health care providers concerning patient and health care provider strategies to limit out-of-pocket costs for cancer care. Curr Oncol 16.4:3Google Scholar